XML 37 R24.htm IDEA: XBRL DOCUMENT v3.8.0.1
Supplementary Balance Sheet Information (Tables)
3 Months Ended
Mar. 31, 2018
Supplementary Balance Sheet Information  
Schedule of cash and cash equivalent balances

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(in thousands)

 

March 31, 2018

 

December 31, 2017

 

Cash and cash equivalents in domestic accounts

 

$

430,819

 

396,577

 

Cash and cash equivalents in foreign accounts

 

 

62,388

 

53,780

 

Total cash and cash equivalents

 

 

493,207

 

450,357

 

Restricted cash included in other assets

 

 

1,031

 

1,013

 

Total cash, cash equivalents and restricted cash shown in the statement of cash flows

 

$

494,238

 

451,370

 

 

 

 

 

 

 

 

 

Schedule of significant components of prepaid expenses and other current assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(in thousands)

 

March 31, 2018

 

December 31, 2017

 

Prepaid expenses

 

$

63,847

 

65,159

 

Income taxes receivable

 

 

42,934

 

41,400

 

R&D state tax credit

 

 

22,642

 

22,642

 

Supplies inventory

 

 

17,465

 

17,072

 

Other

 

 

77,796

 

70,292

 

Total

 

$

224,684

 

216,565

 

 

 

 

 

 

 

 

 

Schedule of significant components and amortization expense of contract acquisition costs

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(in thousands)

 

March 31, 2018

 

December 31, 2017

 

Contract cost assets1, net of accumulated amortization of $179.6 million and $176.4 million as of 2018 and 2017, respectively

 

$

151,758

 

139,249

 

Payments for processing rights2, net of accumulated amortization of $166.3 million as of 2017

 

 

 -

 

119,416

 

Total

 

$

151,758

 

258,665

 

 

 

 

 

 

 

 

 

Schedule of significant components of other current liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(in thousands)

 

March 31, 2018

 

December 31, 2017

 

Accrued third-party commissions

 

$

43,468

 

34,276

 

Accrued expenses

 

 

38,993

 

38,018

 

Dividends payable

 

 

24,351

 

24,886

 

Accrued interest

 

 

13,422

 

19,330

 

Litigation settlements

 

 

2,691

 

1,380

 

Income taxes payable

 

 

1,331

 

185

 

Other

 

 

118,989

 

107,847

 

Total

 

$

243,245

 

225,922

 

 

 

 

 

 

 

 

 

Schedule of income tax effects allocated to and cumulative balance of each component of accumulated other comprehensive income (loss)

 

 

 

 

 

 

 

 

 

 

 

 

 

(in thousands)

    

Foreign currency translation adjustments and transfers from noncontrolling interests

 

Gain on available-for-sale securities

    

Change in  postretirement healthcare plans

 

Total accumulated other comprehensive income/(loss), net of tax

Balance as of December 31, 2017

 

$

(43,464)

 

 

8,446

 

 

(1,130)

 

$

(36,148)

Pretax amount

 

 

13,390

 

 

3,310

 

 

(231)

 

 

16,469

Tax effect

 

 

895

 

 

729

 

 

(84)

 

 

1,540

Net-of-tax amount

 

 

12,495

 

 

2,581

 

 

(147)

 

 

14,929

Balance as of March 31, 2018

 

$

(30,969)

 

 

11,027

 

 

(1,277)

 

$

(21,219)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Schedule of amortization expense

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three months ended

 

 

 

March 31, 

 

(in thousands)

    

2018

    

2017

 

Amortization expense related to:

 

 

 

 

 

 

Contract cost assets1

 

$

10,726

 

8,173

 

Payments for processing rights2

 

 

 -

 

5,219

 

 

 

 

 

 

 

 

1

Upon the Company’s adoption of ASC 606, costs to obtain or fulfill a contract are classified as contract cost assets. As of March 31, 2018, contract cost assets primarily relate to conversion costs. Costs to obtain a contract that qualify for capitalization are immaterial. See further discussion in Note 2. Prior to the Company’s adoption of ASC 606, contract cost assets were referred to as contract acquisition costs and included both conversion costs and payments for processing rights (signing incentives).

2

Upon the Company’s adoption of ASC 606, payments for processing rights (signing incentives) are classified as contract assets in the Company’s consolidated balance sheets. See further discussion in Note 2. Prior to the Company’s adoption of ASC 606, contract cost assets were referred to as contract acquisition costs and included both conversion costs and payments for processing rights.